Find an expert

Dibesh Karmacharya has a Conservation Biology degree from Wayne State College, USA and a PhD on Conservation and Microbiome Genetics from Griffith University, Australia. He worked extensively in the US for Caliper Lifesciences in New Jersey as a research scientist (transgenic animal models). He promoted Genomics and Proteomics technology platforms for GE Healthcare Lifesciences in the US and Canada. He founded the Center for Molecular Dynamics Nepal (CMDN), a wildlife genetics and clinical epidemiology research center and is the Chairman and Executive Director of the Organization. He also founded Intrepid Nepal Pvt. Ltd.-a molecular diagnostics-based Biotechnology Company, and Intrepid Cancer Diagnostics-a leading cancer diagnostic laboratory. He leads several innovative researches in Nepal including building Nepal’s first genetic database of wild tigers through Nepal Tiger Genome Project. He was the Principal Investigator of PREDICT Nepal project-an emerging pandemic threat project. He also founded BIOVAC Nepal Pvt. Ltd. - a vaccine research, development and manufacturing company. He is Wildlife Conservation Society (WCS) Regional Project Coordinator of Pandemic Prevention Leadership Initiative (PPLI). He specializes in One Health and Conservation Genetics.

Dr Kassianos is a Senior Scientist at the Conjoint Internal Medical Laboratory, Queensland Health. Dr Kassianos has made significant contributions to understanding the cell-cell communication between discrete kidney cell and immune cell populations and the therapeutic potential of targeting this cross-talk in chronic kidney disease (CKD). Dr Kassianos has been integral in the development of innovative tools for CKD analytics: (i) in situ/ex vivo profiling for integrating CKD molecular profiles with histopathology; and (ii) preclinical models for screening novel CKD therapeutics. His research is internationally recognised in the field of CKD pathobiology.

Dr Kassianos has contributed to the fields of nephrology and immunology with 41 publications, >2000 career citations (~48 citations/paper) and invited international keynote lectures. Dr Kassianos has a continued record of success in attracting competitive research funding (>$2M as CI), including an NHMRC Dora Lush Scholarship (2007-2010), an RBWH Foundation Fellowship (2012-2014) and two NHMRC Project Grants as CIA (2016-2019; 2019-2022). Dr Kassianos has publications in high-ranking specialist (nephrology, immunology) and generalist journals, including five editorial commentaries in publication issues. These include 21 publications (~50% of his papers) as first or senior author/co-author – of which, 19 (90%) are in top field-weighted journals (Q1, top 10%), including Kidney Int, J Am Soc Nephrol, Cell Death Dis and J Extracell Vesicles. During this time, Dr Kassianos has supervised 5 Early Career Researchers, 5 PhD students (3 to completion) and 2 Masters students (both to completion). Dr Kassianos is also an Editor at Frontiers in Physiology and has contributed to 3 NHMRC grant review panels (2019-2021).

Associate Professor Lauren Kearney is a registered midwife and nurse and is employed as a Conjoint Associate Professor in Midwifery between the School of Nursing, Midwifery and Social Work, UQ and the Women's and Newborn Services, Royal Brisbane and Women's Hospital. Lauren’s teaching expertise is within the postgraduate and higher degree by research areas. Her research track record is strongly focused upon maternal and child health; specifically, within the domains of evaluation of models of care (relating to the perinatal period and early years), intravenous fluid management and access during labour and birth, and facilitators to promote a positive and physiological spontaneous vaginal birth. She is also committed to enhancing women's opportunity to breastfeed and thrive in the postpartum period. Lauren has strong industry collaborations. The recipient of several competitive research grants, Lauren is passionate about improving the experience of health care for women and children through translation of high-quality evidence into practice.

Dr Shelley Keating is an Accredited Exercise Physiologist (AEP) and a Senior Lecturer in Clinical Exercise Physiology at the School of Human Movement and Nutrition Sciences, University of Queensland. With a strong grounding in exercise metabolism and body composition, Dr Keating leads a program of research aimed at changing the way we prioritise, access and deliver lifestyle intervention for people with obesity, non-alcoholic fatty liver disease (NAFLD)/ metabolic-associated fatty liver disease (MAFLD) and type 2 diabetes. Dr Keating holds qualifications in clinical exercise physiology BExSciRehab (Hon-1); MExSpSci (Clinical Exercise Science); PhD (Exercise Physiology) and over 15 years’ experience as an AEP developing, delivering, and disseminating exercise interventions in adults with obesity and related chronic diseases.

I am the Founder and Director of the Hearing Research Unit for Children, leading three research teams investigating (1) middle ear assessments in neonates and infants, (2) hearing screening and diagnostic assessment of school-aged children, and (3) assessment of auditory function of adults and children using electrophysiologic measures including otoacoustic emissions, auditory brainstem response, steady-state evoked potentials, wideband absorbance and wideband tympanometry. My special interest in technological advances and my mission to improve hearing health services through the use of cutting-edge technologies have inspired me to become a world leader in detecting ear diseases in newborns, infants and children. As a world leader in the field of tympanometry and advanced middle ear assessments for children, I have been invited to present on the use of wideband tympanometry with infants and children at international seminars and institutions.

As of July 2024, I have a career total of 249 publications - consisting of 1 book, 4 book chapters, 2 chapters in the Encyclopedia of Human Communication Sciences and Disorders, 132 peer-reviewed journal papers and 110 conference abstracts. Internationally, I am ranked as the most productive author in the world in the field of Tympanometry (a test of middle ear function) and advanced middle ear assessments for all years (1994-2024) and for the last 5 years (Web of Science, February 2024). My work has been cited in 25 different subject categories including Medicine, Health Professions, Neuroscience, Physics, Astronomy, Engineering and Computer Science (Scopus, February 2024). Furthermore, my work has been widely cited internationally by authors in 83 countries ranging from the United States to Europe, Asia and the Middle East (Scopus, February 2024).

I am a consultant Accredited Practising Dietitian and Senior Research Fellow in the Centre for Online Health. I have a PhD in technology-supported lifestyle interventions and delivering dietary education to improve people’s dietary self-management. My research program focuses on technology-enabled health systems and interventions for improving patient-centred care in chronic disease and simplifying nutrition communication for clinicians and people living with chronic conditions. I work in private practice, primarily providing professional consultancy services for kidney nutrition. I also provide consultation for cardiovascular disease and diabetes. You can learn more about my private practice here - https://www.mynutritionclinic.com.au/renal-dietitian/

RESEARCH INTERESTS

My research interests are in 1) Nutrition & Dietetics – primarily diet quality and focusing on methods to improve diet quality in people with chronic kidney disease and other complex chronic conditions; 2) Health Service Delivery & 3) Digital Health – specifically focused on preparing to workforce, codesigning and testing technology-assisted interventions to deliver lifestyle interventions. My current work focuses on technology-enabled health systems and interventions for improving patient-centred care in chronic disease and simplifying nutrition communication for clinicians and people living with chronic conditions.

Emeritus Professor Justin Kenardy is a research and health sector leader. He is also an active disseminator of evidence-based practice in clinical and health psychology, mental health care, and health service delivery. His work is outcomes focussed and is engaged with health users, providers and industry. He is known for his interdisciplinary research work on the psychological impacts of trauma and injury. This is situated at the intersection of mental health, and physical health. His work includes the development and application of preventative, integrative and novel intervention approaches. His published work demonstrates the interdisciplinary and trans-disciplinary approach to collaborating with psychology, medical specialties, allied health, nursing, law, and health economics. He has a practical, respectful and strategic leadership style. He is style is goal-driven and consultative which aims to bring others along to achieve the goal. He is also a mentor and consultant. He provides service to the profession of psychology and the broader community through his range of roles in the Australian Psychological Society, the Psychologists Board of Australia, and the Australian Psychology Accreditation Council, to the field of research through his leadership roles within Queensland Health, the NHMRC, and ISTSS, and to the Jamieson Trauma Institute and Gallipoli Medical Research Institute. He is a Fellow of the Academy of Social Sciences Australia, Fellow of the Australian Psychological Society, Fellow of the Queensland Academy of Arts and Sciences, and a recipient of both the Australian Psychological Society's President's Award for Distinguished Contribution to Psychology and the Ian Campbell Prize for Outstanding Contribution to Clinical Psychology. He is the Editor-in-Chief of the Australian Journal of Psychology.

Professor Bradley Kendall is a clinical academic Gastroenterologist and Cancer Epidemiologist. He is currently a Senior Staff Gastroenterologist (Eminent) at the Princess Alexandra Hospital, Brisbane with over 30 years of experience in clinical practice. His clinical training included Fellowships in the United States at the University of Virginia and the University of California – Los Angeles. Mid clinical career he commenced higher degree studies and in 2014 was awarded a PhD in Cancer Epidemiology from The University of Queensland for his work on Barrett’s oesophagus and obesity. He is actively involved in ongoing research into the epidemiology of pre-malignant and malignant gastrointestinal diseases via his clinical appointment and appointment as a Professor in the School of Medicine at The University of Queensland.

Professor Kendall is involved with national and international collaborations, including projects with the US National Cancer Institute supported International Barrett’s and Esophageal Adenocarcinoma Consortium and the NHMRC supported multicentre Australian Progression of Barrett’s Esophagus to Cancer Network. Currently, he is a Chief investigator in a Cancer Australia funded multicentre Australian collaborative study of the impact of the National Bowel Cancer Screening Program on colorectal cancer outcomes for people with severe mental illness.

I am interested in ion channels in health and disease. Improved technologies for genetic screening is revealing an expanding catalogue of genetic variants to ion channels that give rise neurological disorders, such as epilespy syndromes, autism spectrum disorder and other neurodevelopmental disorders. My main research focus is on neurotransmitter-activated receptor ion channels that are found at neuronal synapses. These include GABA-A, glycine and glutamate (NMDA) receptors. I also work on other ion channesl such as voltage-gated sodium channels and synaptic receptors expressed in invertebrate nervous systems.

I am an expert at recording single ion channel, synaptic and conventional whole-cell currents for functional and pharmacological analyisis.

I collaborate with biophysicists, molecular biologists, geneticists, electrophysiologists and clinicians that specialise in genetic neurological disorders. I have active projects in collaboration with research groups in Australia, USA and Europe.

Cognitive and decision-making problems associated with psychotic disorders like schizophrenia are considered the largest burden for these individuals. They also predict poor functional outcomes, such as maintaining work, social networks, and independent living. I am particularly interested in the relationship between decision-making problems and psychotic symptoms in these disorders; will improving decision-making also reduce psychotic symptoms? To that end, I focus on decision-making tasks that are reliant on brain areas and networks that are implicated in psychosis.

My work aims to understand how corticostriatal circuitry drives decision-making processes, and how this is altered in those with schizophrenia and psychosis. I have taken advantage of my collaborations with basic scientists and clinical researchers with a broad range of expertise to establish a cross-species program of research focussed on decision-making. My research is guided by two fundamental questions:

1. Do decision-making problems in schizophrenia and other psychotic disorders contribute to psychotic symptoms?
2. How can we leverage the mechanistic tools available in rodent neuroscience to identify causative common substrates underlying decision-making problems (and by proxy psychotic symptoms)?

How to build a brain—2.0

For 25 years I was sole chief investigator on 17 NHMRC-ARC project grants that provided funding to decipher the molecular & cellular bases of brain development and regeneration in fish, frogs and mice. This work culminated in the discovery of how to genetically construct an evolutionary novel axon tract in the embryonic brain. This is what I now call an easy problem.

Now my lab has turned its attention to the hardest problem in the natural sciences—how does the brain experience subjective feelings?

Together with my collaborator Professor Deborah Brown (Professor of Philosophy at UQ) we have approached this problem through the sensation of pain and model organisms. We advance the framework of the brain as an inference machine that generates models of its own internal processes (Key and Brown, 2018). When hierarchically arranged, the outputs of these models represent progressive levels of awareness that are antecedent to feelings (i.e. the brain’s experience of its own neural activity). We have proposed a parallel forwards model algorithm and to date have found that fish and molluscs lack the required neural architecture to execute this algorithm and therefore do not feel pain.

Key, B. and Brown, D. (2018) Designing brains for pain: Human to mollusc. Frontiers in physiology 9:1027.

I am a medicinal chemist, and my research focuses on developing chemical modification strategies to enhance the drug-like properties of bioactive peptides, modulating protein-protein interactions, and designing chemical tools to explore biological mechanisms.

Professor Khosrotehrani is a clinical scientist, dermatologist, interested in skin biology, regenerative medicine and skin cancer. He leads the Experimental Dermatology Group at the University of Queensland Diamantina Institute within the Translational Research Institute in Brisbane, Australia. He is also the deputy director of the Australian Skin and Skin Cancer Research Centre in Brisbane. Dr Khosrotehrani obtained his MD from the Cochin-Port Royal School of Medicine at René Descartes University, Paris, France, where he specialized in Dermatology. He is a former graduate of the Ecole Normale Supérieure and the Institut Pasteur of Paris (Université Paris VI, Pierre et Marie Curie) where he obtained a PhD in Physiology and Physiopathology. He is a fellow of the Australian College of Dermatologists and a practising dermatologist at the Princess Alexandra Hospital, Prince Charles Hospital and the Skin and Cancer Foundation’s Queensland Institute of Dermatology.

During his post-doctoral training at Tufts-New England Medical Center, Boston, USA, Dr. Khosrotehrani helped establish the contribution of fetal stem cells to tissue repair by demonstrating their multipotent capacity with a specific potency towards the endothelial lineage. The originality of this work was acknowledged by the NHMRC through an achievement award (2011) and an NHMRC excellence award (2016). He is currently a fellow of the NHMRC of Australia. The main focus of his laboratory is on regenerative medicine and stem cell biology in particular in injury response in skin wounds and skin cancer and how these responses contribute to cancer initiation and progression. Translating his laboratory findings, Dr Khosrotehrani is leading innovative clinical trials in wound healing, keratinocyte cancers and melanoma.

Alexander Khromykh has PhD degree in Molecular Virology. He worked as Postdoctoral Fellow at the University of Ottawa in Canada. He then joined Sir Albert Sakzewski Virus Research Centre in Brisbane and became a laboratory Head in 2001. He moved his laboratory to St Luica campus in 2005 to take an appointment with the School of Chemistry and Molecular Biosciences (SCMB). He was the founding Director of the SCMB’s Centre for Infectious Disease Research and is currently the Deputy Director of the Australian Infectious Diseases Research Centre. He is also the Director of Centre of Excellence and a member of COVID-19 and Zika virus Task Forces in the Global Virus Network.

Professor Kisely is a psychiatrist and public health physician with health services research experience in the UK, Australia & Canada. After graduating from the University of Bristol, he worked in New Zealand in various medical and surgical specialties, before starting psychiatric training in Auckland. He finished his psychiatric training in Western Australia & Manchester, including a Masters degree by research on atypical chest pain. While working as a lecturer in psychiatry he completed a research Doctorate on the effect of physical disorder on psychiatric outcome in primary care. Professor Kisely worked at the Universities of Western Australia and Dalhousie University in Canada before returning to Australia in 2007.